Home › Endometrial Cancer › Indiana › Gary
Endometrial Cancer clinical trials in Gary, IN
3 studies for Endometrial Cancer are looking for participants at sites in and around Gary (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecruitingPhase 2
- Northwest Cancer Center - Hobart, Hobart · 6 mi away
- Saint Mary Medical Center, Hobart · 6 mi away
- Northwest Cancer Center - Crown Point, Crown Point · 12 mi away
- and 1 more
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- UChicago Medicine Northwest Indiana, Crown Point · 12 mi away
- Woodland Cancer Care Center, Michigan City · 25 mi away
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- UChicago Medicine Northwest Indiana, Crown Point · 12 mi away
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY54 studies
- Boston, MA51 studies
- Arlington, VA41 studies
- Nashville, TN38 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- Oklahoma City, OK28 studies
- San Antonio, TX27 studies
- Queens, NY26 studies
- Dallas, TX25 studies
Other studies in Gary
- Non-Small Cell Lung Cancer7 studies
- Lung Cancer7 studies
- Acute Myeloid Leukemia5 studies
- Heart Failure5 studies
- Ovarian Cancer4 studies
- Breast Cancer4 studies
- Atrial Fibrillation4 studies
- COPD3 studies
- Blood Clots3 studies
- Esophageal Adenocarcinoma3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.